Merck Recognized on Fortune's 2022 Change the World List for Expanding Access to HPV Vaccines

RAHWAY, N.J., October 19, 2022 /3BL Media/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune’s 2022 Change the World list. The annual list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Merck was selected for its work expanding global access to the company’s human papillomavirus (HPV) vaccines.

默克（Robert M. Davis）说：“默克公司（Merck）在《财富》（Fortune）的2022年更改世界榜单上的荣誉是一种荣幸，并因使我们的HPV疫苗提供给世界各地的社区而被认可。”“这是过去五年中我们公司列入此列表的第三次，我们为我们继续对全球健康产生的积极影响而感到自豪。我们在这一领域的承诺和努力反映了默克的杰出运营遗产，并为社会创造了价值。重要的是，我们知道，需要做更多的事情来促进健康公平，我们的团队对寻找新的方法和疫苗的新方法充满启发和热情。”

Merck’s access strategy for our HPV vaccines is fully aligned to the company’sEnvironmental, Social, Governance (ESG)策略，特别是默克公司致力于扩大全球人民和社区的访问权。默克对我们的HPV疫苗采取的具体行动包括：

• Collaborating with UNICEF on a长期协议to provide 91.5 million doses for use in Gavi-supported countries from 2021 to 2025;
• Making more than $2 billion in capital investments over the last five years to help increase supply of our HPV vaccines to extend access globally;
• Obtaining prequalification in May 2022 from WHO for our HPV vaccines to be used outside the cold chain for up to four days, helping to enhance accessibility for hard-to-reach populations.

This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list. Merck was previously recognized in2018for its leadership in the fight against Ebola, and in2020为了影响投资计划。财富根据一系列标准选择公司为这一荣誉选择公司，包括他们的工作对满足未满足社会需求的可衡量社会影响，这项工作与成功的业务成果之间的联系，创新程度表明并将其社交有益的工作整合到他们的工作中更大的企业身份。

关于Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visitwww.merck.com和connect with us on推特,Facebook,Instagram,YouTube和LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

风险和不确定性包括但不限于一般行业状况和竞争；一般经济因素，包括利率和货币汇率波动；全球新冠状病毒疾病爆发的影响（Covid-19）；美国和国际上制药行业监管和医疗保健立法的影响；全球医疗保健成本遏制的趋势；竞争对手获得的技术进步，新产品和专利；新产品开发固有的挑战，包括获得监管批准；该公司准确预测未来市场状况的能力；制造困难或延迟；国际经济和主权风险的财务不稳定； dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2021 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

媒体：Patrick Ryan (973) 275-7075
Investors:Peter Dannenbaum (908) 740-1037

Source: Merck & Co., Inc.

View original content here.

Learn more about the Merck’s commitment to diversity and inclusion in its2021/2022 Environmental, Social and Governance (ESG) Progress Report.